Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD53 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | APOBEC3C | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | TMEM253 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | CCDC114 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | KLC1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | MRAS | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | HAX1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | GRIPAP1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | CREM | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | MAP3K14 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |